These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 19046111

  • 1. Maintenance treatment in metastatic breast cancer.
    Sánchez-Muñoz A, Pérez-Ruiz E, Ribelles N, Márquez A, Alba E.
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1907-12. PubMed ID: 19046111
    [Abstract] [Full Text] [Related]

  • 2. Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.
    Orlando L, Cardillo A, Rocca A, Balduzzi A, Ghisini R, Peruzzotti G, Goldhirsch A, D'Alessandro C, Cinieri S, Preda L, Colleoni M.
    Anticancer Drugs; 2006 Sep; 17(8):961-7. PubMed ID: 16940806
    [Abstract] [Full Text] [Related]

  • 3. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
    Halterman PA.
    Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
    [Abstract] [Full Text] [Related]

  • 4. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
    Gligorov J, Lotz JP.
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():53-66. PubMed ID: 19101794
    [Abstract] [Full Text] [Related]

  • 5. Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes.
    Tanabe M, Ito Y, Tokudome N, Sugihara T, Miura H, Takahashi S, Seto Y, Iwase T, Hatake K.
    Breast Cancer; 2009 Dec; 16(4):301-6. PubMed ID: 19205831
    [Abstract] [Full Text] [Related]

  • 6. Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185).
    Pandya KJ, Hu P, Osborne CK, Falkson G, Tormey DC, Eastern Cooperative Oncology Group.
    Am J Clin Oncol; 2007 Apr; 30(2):113-25. PubMed ID: 17414459
    [Abstract] [Full Text] [Related]

  • 7. [Chemotherapy for metastatic breast cancer].
    Schmid P, Possinger K.
    Zentralbl Gynakol; 2006 Dec; 128(6):318-26. PubMed ID: 17213969
    [Abstract] [Full Text] [Related]

  • 8. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
    Trudeau ME, Clemons MJ, Provencher L, Panasci L, Yelle L, Rayson D, Latreille J, Vandenberg T, Goel R, Zibdawi L, Rahim Y, Pouliot JF.
    J Clin Oncol; 2009 Dec 10; 27(35):5906-10. PubMed ID: 19858391
    [Abstract] [Full Text] [Related]

  • 9. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.
    Munoz R, Man S, Shaked Y, Lee CR, Wong J, Francia G, Kerbel RS.
    Cancer Res; 2006 Apr 01; 66(7):3386-91. PubMed ID: 16585158
    [Abstract] [Full Text] [Related]

  • 10. First-line chemotherapy for metastatic breast cancer.
    Telli ML, Carlson RW.
    Clin Breast Cancer; 2009 Jun 01; 9 Suppl 2():S66-72. PubMed ID: 19596645
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy of advanced breast cancer.
    Szántó J.
    Acta Med Hung; 1994 Jun 01; 50(3-4):185-93. PubMed ID: 8587832
    [Abstract] [Full Text] [Related]

  • 12. The use of chemotherapy in metastatic breast cancer.
    Garber JE, Henderson IC.
    Hematol Oncol Clin North Am; 1989 Dec 01; 3(4):807-21. PubMed ID: 2481671
    [Abstract] [Full Text] [Related]

  • 13. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
    Mlineritsch B, Schabel-Moser R, Andel J, Fridrik M, Moik M, Mayer P, Russ G, Rass C, Greil R, Arbeitsgemeinschaft medikamentöse Tumortherapie Study Group.
    Onkologie; 2009 Feb 01; 32(1-2):18-24. PubMed ID: 19209014
    [Abstract] [Full Text] [Related]

  • 14. [Therapy of metastatic breast cancer].
    Eidtmann H, Jonat W.
    Ther Umsch; 1993 May 01; 50(5):352-8. PubMed ID: 7690992
    [Abstract] [Full Text] [Related]

  • 15. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P, Fohlin H, Arnesson LG, Dufmats M, Nordenskjöld K, Nordenskjöld B, Stål O, South-East Sweden Breast Cancer Study Group.
    Acta Oncol; 2009 May 01; 48(4):504-13. PubMed ID: 19235568
    [Abstract] [Full Text] [Related]

  • 16. Impact of chemotherapy beyond the first line in patients with metastatic breast cancer.
    Dufresne A, Pivot X, Tournigand C, Facchini T, Altweegg T, Chaigneau L, De Gramont A.
    Breast Cancer Res Treat; 2008 Jan 01; 107(2):275-9. PubMed ID: 17380382
    [Abstract] [Full Text] [Related]

  • 17. A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.
    Coudert B, Focan C, Genet D, Giacchetti S, Cvickovic F, Zambelli A, Fillet G, Chollet P, Amoroso D, Van Der Auwera J, Lentz MA, Marreaud S, Baron B, Gorlia T, Biville F, Lévi F.
    Chronobiol Int; 2008 Sep 01; 25(5):680-96. PubMed ID: 18780198
    [Abstract] [Full Text] [Related]

  • 18. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH, Goldberg RM.
    Oncologist; 2008 Oct 01; 13(10):1074-83. PubMed ID: 18922828
    [Abstract] [Full Text] [Related]

  • 19. [High-dose chemotherapy for metastatic breast cancer].
    Lalle M, De Rosa L, Perillo A, Scambia G, D'Aprile M, Antimi M.
    Clin Ter; 2004 Oct 01; 155(7-8):305-15. PubMed ID: 15553258
    [Abstract] [Full Text] [Related]

  • 20. [Chemotherapy of cancer of the breast in the metastatic phase].
    Clavel M, Biron P, Chauvin F, Guastalla JP, Rebattu P, el Foudeh M.
    Bull Cancer; 1989 Oct 01; 76(1):75-85. PubMed ID: 2653473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.